ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 152

Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset

Marco Antivalle1,2, Maria Chiara Ditto3, Alberto Batticciotto3, Rossella Talotta3, Maria Chiara Gerardi3, Alessandra Mutti3, Fabiola Atzeni3 and Piercarlo Sarzi-Puttini3, 1Rheumatology, Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 2Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, 3Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: Diagnostic criteria and fibromyalgia

Session Information

Date: Sunday, November 5, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The 2010/2011 fibromyalgia (FMS) diagnostic criteria (1) were recently revised, with the addition of a generalized pain criterion in order to avoid misclassification of regional pain syndromes; furthermore, the diagnosis of fibromyalgia is now valid irrespective of other diagnoses. Aim of the present study was to evaluate whether patients classified as having (2016+) or not having (2016-) FMS by 2016 revised criteria truly represent different populations.

Methods: 334 patients (306 F and 28 M) with a diagnosis of FMS according to 2011 criteria were included in the study;  mean age was 46.82 yrs (range 16 – 75), and  mean disease duration 6.25 yrs (range 3 months -34 yrs). Widespread Pain Index (WPI) and Symptom Severity Scale (SSS) were assessed by a localized version of the Fibromyalgia Survey Questionnaire; furthermore, patients were asked to report the presence or absence -in the last 7 days- of each of the 41 somatic symptoms suggested by the original 2010 classification paper (2). An evaluation of overall pain level in the last 7 days (0-10 numeric rating scale, NRS), and of fatigue by the FACIT-Fatigue questionnaire were available in 101 and 137 patients respectively. Statistical analysis was performed by IBM SPSS v 22. Differences of mean values and of proportions were evaluated by parametric or non-parametric methods as appropriate.

Results: the diagnosis of FMS was confirmed by 2016 criteria in  290 (86.8%) patients, and not confirmed in  44 (13.2%) patients. Mean age (47.62 ± 10.6 yrs vs 46.69 ± 11.7 yrs, p=0.625), mean disease duration (6.27 ± 6.37 vs 6.25 ± 6.10 yrs, p=0.982), the percentage of females (93.2% vs 91.4%, p=0.688), and the association  with other clinically relevant diseases (27.3% vs 18.6%, p=0.179) were not different in the 2016- group as compared to 2016+ group. 2016- patients had significantly lower values of polysymptomatic distress scale (PSD: 16.59 ± 2.4  vs 21.86 ± 4.5 p < 0.001), and of pain-related variables (WPI: 7.57 ± 2.1  vs 12.66 ± 3.4, p< 0.001; TP: 10.54±5.4 vs  13.28 ± 4.3,  p=0.001; NRS:  5.64 ± 2.9 vs 7.46 ± 1.9  p=0.022). SSS was similar in the 2 groups (9.03 ± 1.9 vs 9.20 ± 1.9 p=0.599), but the number of somatic symptoms reported was significantly lower in 2016- patients (14.44 ± 5.0 vs 17.49 ± 6.6 p=0.005, Fig. 1), which reported higher levels of fatigue (FACIT-Fatigue 28.3 ± 10.8 vs 21.17 ± 10.0, p=0.010).

Conclusion: The rate of disagreement between 2011 and 2016 criteria (13.2%) in our study is very close to the results (13.8%) reported in the only comparison study published to date (3). Patients failing to meet 2016 criteria seem to represent a truly different population, characterized by lower polysymptomatic distress, lower overall pain, and fewer somatic symptoms.

References:

1.                  Wolfe F,  et al. Semin Arthritis Rheum. 2016 Dec;46(3):319-329

2.                  Wolfe F,  et al. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10

3.                  Ablin JN, Wolfe F. J Rheumatol. 2017 Jun 1. [Epub ahead of print]


Disclosure: M. Antivalle, None; M. C. Ditto, None; A. Batticciotto, None; R. Talotta, None; M. C. Gerardi, None; A. Mutti, None; F. Atzeni, None; P. Sarzi-Puttini, None.

To cite this abstract in AMA style:

Antivalle M, Ditto MC, Batticciotto A, Talotta R, Gerardi MC, Mutti A, Atzeni F, Sarzi-Puttini P. Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/patients-failing-to-fulfill-2016-criteria-for-fibromyalgia-represent-a-truly-different-population-subset/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-failing-to-fulfill-2016-criteria-for-fibromyalgia-represent-a-truly-different-population-subset/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology